Aurora Therapeutics has launched with $16 million in seed funding from Menlo Ventures to pursue bespoke CRISPR-based therapies for ultra-rare genetic diseases. The company is …
Read More
Schrödinger will integrate Eli Lilly’s AI drug discovery platform, TuneLab, into its cloud-based molecular design environment, LiveDesign. The partnership allows existing Schrödinger clients to access …
Read More
San Francisco-based Chai Discovery has partnered with Eli Lilly to integrate Chai’s molecular design platform into Lilly’s discovery workflows and develop a bespoke AI model …
Read More
Iktos and Servier have entered a multi-year, multi-target research collaboration under which Iktos will apply its AI-driven molecular design and automated synthesis platform to discover …
Read More
Eli Lilly is making its AI/ML platform, TuneLab, broadly accessible through an integration with San-Francisco based Benchling, bringing models trained on over $1 billion worth …
Read More
Palo-Alto based Medable has launched a new AI agent to automate the trial master file (TMF) process, one of the most labor-intensive components of clinical …
Read More
